Dorabawila et al.; 'Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant'
(palexander.substack.com)https://palexander.substack.com/p/dorabawila-et-al-effectiveness-of?s=r“During Omicron variant predominance, VE against infection declined rapidly for NYS children 5- 11 years, with low protection by one month following full-vaccination. Among children 12-17, protection declined substantially, albeit more slowly than observed among younger children.”
In Normal Speak: COVID mRNA GMO jab does not work in the first month!
